Swiss National Bank Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Swiss National Bank raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 590,900 shares of the medical device company’s stock after acquiring an additional 2,400 shares during the period. Swiss National Bank owned approximately 0.30% of Cooper Companies worth $65,200,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of COO. Quent Capital LLC increased its stake in Cooper Companies by 300.0% in the 1st quarter. Quent Capital LLC now owns 828 shares of the medical device company’s stock valued at $84,000 after purchasing an additional 621 shares in the last quarter. Orion Portfolio Solutions LLC grew its position in Cooper Companies by 268.3% during the first quarter. Orion Portfolio Solutions LLC now owns 11,546 shares of the medical device company’s stock valued at $1,171,000 after acquiring an additional 8,411 shares during the period. Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of Cooper Companies by 272.0% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 99,722 shares of the medical device company’s stock worth $10,118,000 after purchasing an additional 72,915 shares during the period. Acadian Asset Management LLC increased its position in shares of Cooper Companies by 300.0% in the first quarter. Acadian Asset Management LLC now owns 720 shares of the medical device company’s stock worth $73,000 after acquiring an additional 540 shares in the last quarter. Finally, Covestor Ltd increased its holdings in Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $99.05 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average price is $106.48 and its two-hundred day moving average price is $98.18. The Cooper Companies, Inc. has a twelve month low of $82.21 and a twelve month high of $112.38. The company has a market cap of $19.73 billion, a PE ratio of 55.03, a price-to-earnings-growth ratio of 2.15 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter last year, the company earned $0.84 EPS. The company’s revenue was up 7.8% on a year-over-year basis. On average, analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Transactions at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This trade represents a 24.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 256,373 shares of company stock worth $27,637,427. Company insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on COO shares. Morgan Stanley raised their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Finally, Robert W. Baird upped their target price on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.